4//SEC Filing
Martins Eduardo Bruno 4
Accession 0001104659-23-082727
CIK 0001400118other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 4:17 PM ET
Size
12.5 KB
Accession
0001104659-23-082727
Insider Transaction Report
Form 4
Martins Eduardo Bruno
Chief Medical Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2023-07-18−44,009→ 0 totalExercise: $13.51Exp: 2033-04-19→ Common Stock (44,009 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-07-18−198,132→ 0 totalExercise: $6.36Exp: 2031-02-18→ Common Stock (198,132 underlying) - Award
Stock Option (Right to Buy)
2023-07-18+198,132→ 198,132 totalExercise: $6.36Exp: 2031-02-18→ Series A Common Stock (198,132 underlying) - Award
Stock Option (Right to Buy)
2023-07-18+44,009→ 44,009 totalExercise: $13.51Exp: 2033-04-19→ Series A Common Stock (44,009 underlying)
Footnotes (3)
- [F1]Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.
- [F2]25% of the shares underlying this option vested and became exercisable on February 16, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- [F3]The shares underlying this option shall vest in forty-eight (48) equal monthly installments following April 20, 2023, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Sagimet Biosciences Inc.
CIK 0001400118
Entity typeother
Related Parties
1- filerCIK 0001670431
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 4:17 PM ET
- Size
- 12.5 KB